PCSK9 and colorectal cancer: In a recent biochemical study [135], an aptamer PL1 and Pcsk9 siRNA were able to potentiate anti PD-1/PD-L1 therapies in human colorectal cancer cells through enhancement of IFN-γ and Granzyme B expression.